Evoqua Water Technologies - AQUA Stock Forecast, Price & News

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evoqua Water Technologies in the last twelve months. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" AQUA shares.
View AQUA analyst ratings or view top-rated stocks.

7 equities research analysts have issued twelve-month price objectives for Evoqua Water Technologies' shares. Their AQUA share price forecasts range from $40.00 to $50.00. On average, they expect the company's stock price to reach $44.86 in the next twelve months. This suggests a possible upside of 35.6% from the stock's current price.
View analysts price targets for AQUA or view top-rated stocks among Wall Street analysts.

Evoqua Water Technologies' stock was trading at $46.75 at the start of the year. Since then, AQUA shares have decreased by 29.3% and is now trading at $33.07.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 15th 2022.
View our AQUA earnings forecast.

Evoqua Water Technologies Corp. (NYSE:AQUA) posted its quarterly earnings results on Tuesday, August, 2nd. The company reported $0.20 EPS for the quarter, hitting analysts' consensus estimates of $0.20. The business had revenue of $439.33 million for the quarter, compared to the consensus estimate of $432.65 million. Evoqua Water Technologies had a net margin of 3.48% and a trailing twelve-month return on equity of 14.06%.

Evoqua Water Technologies updated its FY 2022 earnings guidance on Tuesday, August, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.64 billion-$1.70 billion, compared to the consensus revenue estimate of $1.70 billion.

85 employees have rated Evoqua Water Technologies Chief Executive Officer Ronald C. Keating on Glassdoor.com. Ronald C. Keating has an approval rating of 54% among the company's employees. This puts Ronald C. Keating in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Evoqua Water Technologies investors own include Melinta Therapeutics (MLNT), Cara Therapeutics (CARA), AT&T (T), Pfizer (PFE), Marvell Technology (MRVL), PayPal (PYPL), AbbVie (ABBV), Walt Disney (DIS), Roku (ROKU) and Exxon Mobil (XOM).

(AQUA) raised $500 million in an initial public offering on Thursday, November 2nd 2017. The company issued 27,800,000 shares at $17.00-$19.00 per share. Credit Suisse, J.P. Morgan and RBC Capital Markets acted as the underwriters for the IPO and Citigroup, Goldman Sachs, Morgan Stanley, Baird, Raymond James, Stifel and Wells Fargo Securities were co-managers.

Evoqua Water Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "AQUA."

Shares of AQUA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AQUA stock can currently be purchased for approximately $33.07.

Evoqua Water Technologies (NYSE:AQUA) has a market capitalization of $4.02 billion and generates $1.46 billion in revenue each year. The company earns $51.48 million in net income (profit) each year or $0.47 on an earnings per share basis.

The company employs 4,000 workers across the globe.

Evoqua Water Technologies' mailing address is 210 SIXTH AVENUE, PITTSBURGH PA, 15222. The official website for the company is www.evoqua.com. The company can be reached via phone at (724) 772-0044 or via email at dan.brailer@evoqua.com.